1. Signaling Pathways
  2. Immunology/Inflammation
  3. Fc Receptor (FcR)
  4. Fc Receptor (FcR) Ligand

Fc Receptor (FcR) Ligand

Fc Receptor (FcR) Ligand (1):

Cat. No. Product Name Effect Purity
  • HY-P99037
    Nipocalimab
    Ligand 99.90%
    Nipocalimab (M281) is a fully humanized, recombinant, and non-glycosylated IgG1 monoclonal antibody. Nipocalimab can bind to the IgG-binding site of FcRn with high affinity and inhibit the transplacental transfer of IgG. Nipocalimab can be used in the research of fetal and neonatal hemolytic disease, myasthenia gravis, and various IgG-mediated autoimmune diseases.